Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Adagene's Masked CTLA-4 Antibody ADG126 To Be Highlighted In Dual Oral Presentations At 2025 CSCO Meeting; Data Highlights Include Phase 1b/2 Results In MSS CRC And Combination With Pembrolizumab

Author: Benzinga Newsdesk | September 05, 2025 09:01am

Posted In: ADAG